Researchers say their clinical trial is the first to show that personalized drug treatments based on tumor DNA are safe and ...

A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...

A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic has developed a new artificial intelligence (AI) model that can help ...

Even with access to cutting-edge data — sometimes as detailed as a patient’s entire genome — doctors often lack the insight needed to make the best treatment choices. Determining how a disease will ...

Mayo Clinic researchers developed MedEduChat, an AI-powered EHR tool that delivers personalized prostate cancer education ...

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

Genetic risk models, including PREMMplus and BOADICEA/CanRisk, refine breast cancer risk assessment by incorporating genetic status and polygenic risk scores. Challenges in classifying gene variants, ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...